Thrombotic and Haemorrhagic Complications in Patients with Heart Valve Prostheses: A More Complex Matter Than Proper Prothrombin Time Ratios

• References

• 1 Cortellazzo S, Finazzi G, Viero P, Galli M, Remuzzi A, Parenzan L, Barbui T. Thrombotic and haemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993; 69: 316-320
• 2 Cevese PG. Long-term results of 212 xenograft valve replacements. J Cardiovasc Surg 1975; 16: 639-642
• 3 Fuster V, Badimon L, Badimon JJ, Chesebro J. Prevention of thromboembolism induced by prosthetic heart valves. Sem Thromb Haemost 1988; 14: 50-58
• 4 Ionescu MI, Pakrashi BC, Mary DAS. Long-term evaluation of tissue valves. J Thor Cardiovasc Surg 1977; 68: 361
• 5 Stein PD, Kantrowitz A. Antithrombotic therapy in mechanical and biological prosthetic heart valves and saphenous vein bypass grafts. Chest 1989; 95 (02) 107S-117S
• 6 Stinson EB, Griepp RB, Oyer PE. Long-term experience with porcine aortic valve xenografts. J Thor Cardiovasc Surg 1977; 73: 54-63
• 7 Edmonds LH. Thromboembolic complications of current cardiac valvular prostheses. Ann Thor Surg 1981; 34: 96-107
• 8 Fuster V, Pumphrey ChW, McGoon MD, Chesebro JH, Pluth JR, McGoon DC. Systemic thromboembolism in mitral and aortic Stan-Edwards prostheses: a 10-19 year follow-up. Circulation 1982; 66 (Suppl. 01) 157-161
• 9 Patrassi GM, Cardin G, Schiavinato ML, Russo L, de MozziP, Schivazappa L, Girolami A. Decreased thrombotic mortality and morbidity after valvular cardiac surgery as a consequence of adequate coumarin anticoagulation. A retrospective study in 516 patients. Folia Haematol 1975; 5: 690-699